Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Latest News
    • Groundbreaking...

    Groundbreaking discovery-Fast-acting drinkable antidote in sight for cholera epidemics

    Written by Anjali Nimesh Nimesh Published On 2018-03-12T19:05:34+05:30  |  Updated On 12 March 2018 7:05 PM IST
    Groundbreaking discovery-Fast-acting drinkable antidote in sight for cholera epidemics

    Cholera is caused by a toxin released by bacteria, cholera toxin, which binds to the intestinal wall, causing massive fluid loss through diarrhea. The binding has long been believed to be dependent on a specific receptor in the intestine, GM1.The researchers are in process of a producing a fast-acting drinkable antidote especially for cholera epidemics that can put both GM1 and other receptors out of play. This could complement other emergency initiatives in areas where sufficient vaccination protection is lacking.The study has been published in the journals PLOS Pathogens and ACS Infectious Disease.


    “This is not about a vaccine but rather a drinkable protection that can be distributed during an ongoing cholera epidemic to reduce its spread, a drink that blocks the cholera toxin so that it doesn’t reach the intestinal mucous membrane, where all the chaos otherwise gets under way,” says Ulf Yrlid, associate professor of immunology at Sahlgrenska Academy, Sweden.





    Those responsible for the studies are Ulf Yrlid along with colleagues in Gothenburg and a research team at the University of Texas Southwestern Medical Center in Dallas. To some extent, their discoveries run counter to earlier notions about the life-threatening disease.

    Cholera is caused by a toxin released by bacteria, cholera toxin, which binds to the intestinal wall, causing massive fluid loss through diarrhea. The binding has long been believed to be dependent on a specific receptor in the intestine, GM1.

    Current research shows, however, that mice that completely lack GM1 also get diarrhea after drinking water containing cholera toxin. In addition, the fluid loss could be prevented in human intestinal tissue exposed to cholera toxin by adding molecules that block binding to completely different receptors than GM1.

    “The big takeaway for us is that we have shown that it’s not quite as simple as people have maintained for decades. GM1 is indeed a very powerful receptor in this context, but unlike the other receptors, there is very little of it in the human intestine,” says Ulf Yrlid.

    According to the researchers, the results also offer the possibility of producing a drinkable antidote that can put both GM1 and other receptors out of play. This could complement other emergency initiatives in areas where sufficient vaccination protection is lacking.

    “The problem with vaccines is that they work less well in developing countries due to malnutrition and poor health, especially when it comes to small children. This is not unique for cholera vaccine, but applies to the entire field of vaccination,” says Ulf Yrlid.

    “If we could use molecules that bind effectively to the cholera toxin and thereby prevent the toxin from attaching to the intestine, we could then immediately reduce the spreading in an affected area, even if people are not vaccinated or don’t have sufficient protection. One advantage of the molecules we modify is they are sugar molecules that already are present in breast milk to a great extent and therefore are safe to drink,” he concludes.

    For more details click on the link :

    1. PLOS Pathogens, 2018; 14 (2): e1006862 DOI: 10.1371/journal.ppat.1006862

    2. ACS Infectious Diseases, 2018; DOI: 10.1021/acsinfecdis.7b00085


    choleraCholera Epidemicscholera toxindiarrheajournals PLOS Pathogens and ACS Infectious Diseasetoxinvaccination
    Source : Press Release

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Anjali Nimesh Nimesh
    Anjali Nimesh Nimesh
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok